KB-R7943 treatment improved survival and reduced P. aeruginosa bacterial burden in mice with cystic fibrosis transmembrane conductance regulator (CFTR) knockout, demonstrating efficacy in cystic fibrosis-specific lung infection (Rimessi et al., 2020). Here, CFTR is linked to cystic fibrosis.